Directors and Officers Insurance for Pre-Revenue Startups

Directors and Officers insurance protects the people running a company, not the company itself, when someone sues over a management decision. For a pre-revenue startup, that distinction matters more than it does almost anywhere else in the business, because founders at this stage carry personal liability with none of the revenue, governance track record, or institutional polish that would normally convince an underwriter (or a plaintiff's attorney) to look elsewhere.

Here's the setup nobody puts on the pitch deck: before there's a product, a customer, or a dollar of revenue, there are already pitch decks, private placement memoranda, and a string of verbal promises made to whoever wrote the first check. Every one of those documents and conversations can become the basis of a claim. And in private placements, intent isn't always a shield. A founder doesn't need to have deliberately lied for a misrepresentation claim to stick; an investor may argue that fuller or more accurate information would have changed how much they were willing to pay for their shares. No smoking gun required. Just a slide that turned out to be wrong.

Without coverage, that exposure lands on personal assets: homes, savings, whatever retirement account a founder has managed to scrape together while paying themselves a below-market salary to stretch runway. It doesn't matter whether the underlying claim has merit. Defense costs start accruing the moment a complaint is filed, and somebody has to pay them while the question of merit gets sorted out in court.

There's also a quieter cost to skipping D&O early: experienced executives and board candidates routinely decline to join startups that don't have it. A VP of Engineering with quarter-million-dollar equity offers on the table from three companies isn't going to take personal liability risk at the one without a policy in place. Coverage functions as a hiring credential as much as a legal one.

The scale of the exposure is not trivial. Roughly 1,300 claims get made against directors and officers of American businesses each year, and the average reported loss runs around $400,000. For a pre-revenue founder, that number alone can exceed a lifetime of savings, well before any settlement gets negotiated.

How a D&O policy is actually structured, and why the architecture matters for founders

Almost every D&O policy is quoted as a single package covering three distinct things, labeled Side A, Side B, and Side C. Knowing the difference matters, because each one protects a different party and behaves differently when money runs out.

Side A pays defense and settlement costs directly to individual directors and officers, but only when the company can't or won't indemnify them, say, in a bankruptcy where there's no corporate cash left to cover anyone. This is the layer that survives insolvency, and for founders it's the part that matters most when everything else has fallen apart.

Side B reimburses the company when it indemnifies its own directors and officers, meaning the company pays first and the insurer pays it back. In ordinary operations, this is the piece that gets triggered most often; it's the boring, workhorse coverage that handles most day-to-day claims.

Side C, sometimes called entity coverage, protects the company itself, most commonly against securities-related claims. For private companies the scope is narrower than people expect: usually it's limited to allegations tied to fundraising or M&A, and the exact boundaries shift from one policy form to the next. Founders with venture backing generally need all three sides bundled together, not Side A on its own. Side A alone protects the individuals but leaves the company naked against the kind of investor lawsuit that's statistically most likely to show up first.

Here's the part that trips people up: the whole policy shares one pool of money. A large Side C claim against the entity draws from the same limit that's supposed to protect individual directors under Side A. Some larger programs solve this by carving out a separate Side A tower, insulated from entity-level claims, but that's a feature of bigger, more expensive programs, not something a seed-stage startup typically has access to.

And because legal defense is billed continuously rather than at the end of a case, the limit erodes in real time. A six-figure legal bill run up before a case even reaches discovery is a realistic outcome in how these claims play out. Every dollar spent defending a claim is a dollar no longer available to pay a settlement or judgment. That's why insurance people call this a "wasting" or "eroding" policy: the tank drains while the engine's still running.

The single most consequential technical detail in the whole contract, though, is the claims-made trigger. Unlike general liability insurance, which responds to events that occurred during the policy period, D&O responds to claims made during the policy period, regardless of when the underlying conduct happened. A pitch deck built in year one can generate a lawsuit in year four, and what matters is whether there's an active policy in force at the moment the claim is filed, not whether one existed back when the deck was built.

That's where the retroactive date comes in. It marks the earliest point in time for which the policy will cover wrongdoing. If coverage lapses, even for a short gap between carriers, or if the retroactive date resets during a carrier switch, any conduct that happened before that date falls into a hole no policy will ever fill. Buying coverage early locks in an early retroactive date, which is a real structural advantage: a company that has carried D&O since its seed round has protection reaching back to the seed round, even if the claim doesn't surface until Series C.

What actually gets founders sued at the pre-revenue stage

Employment disputes are among the most common claim types at early-stage startups. Wrongful termination, discrimination, harassment, retaliation, these suits routinely name the CEO or a VP personally, right alongside the corporate entity. A founder who fires someone poorly (which, at a ten-person company, tends to mean fires someone personally and awkwardly) can end up a named defendant.

Investor misrepresentation is the second major category, and it's the one baked directly into the fundraising process. Financial projections that don't pan out, market-size claims that turn out to be optimistic, technical capabilities described in a pitch deck that the product doesn't quite deliver, any of these can morph into a securities fraud or misrepresentation claim from an early investor, sometimes years after the check cleared.

Breach of fiduciary duty claims tend to show up around inflection points: a pivot that guts a product line, an exclusivity deal that locks out a class of shareholders, acquisition terms that favor some investors over others, or a down round that dilutes early backers. Minority shareholders who feel shortchanged by any of these moves can argue the board failed its basic duty of care.

Then there's the regulatory category: SEC informal inquiries, state attorney general subpoenas, FTC investigations. These start as corporate matters and end up, procedurally, naming individual officers.

AI governance claims are the fastest-growing slice of this pie. There were 17 AI-related securities cases filed in 2025, up from a similar number in 2024, and more than double the 7 filed in 2023. That's a trend line worth sitting with for a second: it roughly doubled over two years, and it's concentrated in exactly the sectors, technology, fintech, life sciences, where pre-revenue founders are most likely to be making bold claims about what their product can do before it's fully built.

Cybersecurity oversight claims work a little differently than people assume. The lawsuit isn't about the breach itself, that's a separate matter handled under a cyber policy. The D&O claim is about whether the board failed to govern cyber risk in the first place: did they have a plan, did anyone review it, was risk oversight actually happening at the board level. Two different failures, two different policies.

Zoom out and the macro numbers explain why any of this matters to a company that hasn't shipped a product yet. Securities class action filings hit 222 in 2024, up from 212 in 2023. In the first half of 2025, the Maximum Dollar Loss Index reached $1.851 trillion, a jump of 154% over the prior six months. That's the litigation climate a pre-revenue startup's decisions today will eventually be judged against, whenever a claim surfaces down the line. Claims cluster around financial pressure, rapid growth, and strategic pivots, which happen to be the exact conditions that define a startup's early life.

When investors will require coverage and what they will demand

Pre-seed and seed investors generally don't contractually require D&O. Some slip in language requiring the company to obtain "customary" coverage, but enforcement tends to be loose to nonexistent at this stage; nobody's chasing a two-person startup over a missing insurance certificate.

Series A changes that completely. Most institutional VCs require D&O once a partner takes a board seat, because that partner wants personal liability protection in place before casting a first vote on anything. The standard term sheet asks for minimum limits between $3 million and $5 million, bound within 60 to 90 days of the financing close.

This isn't a soft suggestion buried in boilerplate. It's typically written into the Investors' Rights Agreement as a contractual condition, which means missing the binding deadline is a covenant breach, not an oversight to apologize for later. Founders who wait until after the term sheet is signed, treating the insurance purchase as a diligence afterthought, risk delaying the round or missing that binding deadline outright. Underwriting takes real time, especially for companies with a messy cap table or a dispute sitting somewhere in the drawer.

Coverage requirements only climb from there. Series B and later rounds typically require limits of $5 million to $10 million or more, since each new investor class adds another party whose claims could draw down the shared pool. Pre-IPO programs can stack substantially higher limits across multiple layered towers. The trajectory from seed to exit is one continuous climb in required limits, which is exactly why anchoring an early retroactive date matters structurally: a company that bought its first policy at seed and kept it continuously in force carries that early date all the way to IPO.

There's a softer signal buried in all this too. Early D&O purchase can signal to the board and incoming investors that the founding team takes governance seriously before anyone's forcing them to.

What coverage costs at the pre-revenue and seed stage, and what moves the price

Premiums softened through 2024 and into 2025 as new carriers entered the market and competitive pressure increased. Companies with clean claims histories are seeing modest rate decreases carry into 2026 renewals. That said, prior claims, regulatory inquiries, or a headcount that doubled in six months will still produce a flat or rising renewal, softening market or not.

For a pre-seed or seed company that's raised under $10 million, expect somewhere around $3,500 to $6,000 a year for $1 million of coverage. Some carriers run first-year promotional pricing for low-risk SaaS companies closer to $2,500. Once a company reaches Series A, having raised $10 million to $25 million, pricing runs roughly $5,000 to $10,000 a year for $1 million to $3 million in coverage. As a general reference point, D&O for startups tends to fall between $3,000 and $7,000 per $1 million of coverage, and a $2 million policy might land anywhere from $5,000 to $13,000 depending on the risk profile underwriters see.

Industry matters more than most founders expect. A manufacturer or a biotech company will typically pay roughly double what a comparable SaaS company pays for the same limit, and fintech, crypto, healthcare, and adtech companies land in a similarly elevated tier because of the regulatory exposure baked into those industries.

What actually moves the needle on price? Underwriters generally look for signs that a company is well-governed and low-risk before setting a price. Each positive signal reduces the perceived probability of the kind of mismanagement claim underwriters actually worry about, and pricing follows accordingly.

Worth sitting with the wasting-policy math again here, because it's not abstract. The average reported loss per D&O claim is around $400,000, and top defense counsel now charges up to $1,800 an hour, up from roughly $1,000 five years ago. A single contested investor claim can burn through a $3 million limit in legal fees alone before a settlement number ever gets discussed. For budgeting purposes at the pre-revenue stage, the seed-stage price range above is the right benchmark. For setting the actual limit, the number to plan around is whatever the Series A requirement will be at the next raise, not the number that feels comfortable today.

The coverage gaps that catch pre-revenue founders by surprise

D&O alone does not cover employment claims, which is a genuinely uncomfortable gap given that employment disputes are the single most common claim type at small startups. Covering that exposure requires either a combined D&O and Employment Practices Liability (EPLI) policy or a standalone EPLI policy. At seed and Series A, most carriers offer the combined product, so this is usually a matter of asking for it rather than shopping separately.

Wage and hour disputes, FLSA overtime violations, misclassifying someone as exempt when they should be non-exempt, may fall outside the coverage EPLI policies provide. These claims are increasingly common at startups that scale headcount fast without updating job classifications, and they require their own specialized coverage layered in separately.

Then there's the insured-versus-insured exclusion, standard language in nearly every policy that blocks one insured person from suing another insured person and having the policy respond. Sounds reasonable on paper, until a bankruptcy trustee steps into the company's shoes and sues the founders directly. That exclusion triggers, and suddenly the policy that was supposed to protect the founders doesn't.

Fraud and criminal acts get excluded too, but only once there's a final adjudication establishing the misconduct actually happened. Before that point, defense costs are typically advanced, meaning founders facing an accusation still get a defense funded while the matter is litigated. If the founder loses and fraud gets established, the carrier can claw those advanced costs back. Coverage exists during the fight, not after a guilty verdict.

Cyber events split the same way described earlier: the breach itself belongs to a separate cyber policy, while D&O only responds to the claim that the board failed to govern cyber risk properly. Two different exposures, two different policies, and conflating them is an easy mistake.

The retroactive date gap deserves one more mention here, because it's not a technicality tucked into fine print, it's the actual mechanism by which early decisions go unprotected. Any conduct predating the retroactive date is permanently uninsured, no matter when the claim eventually surfaces. And the shared-limit dynamic between Side C and Side A bears repeating too: a big entity-level claim can quietly drain the same pool that's supposed to protect individual directors, which means a quoted limit that looks generous on paper might not be adequate once a real claim shows up.

What underwriters look at when evaluating a pre-revenue startup, and how to prepare

Carriers treat pre-revenue companies as a higher-uncertainty bet by default. No revenue track record, thin financial controls, decision-making concentrated in one or two founders who are also probably answering support tickets and reviewing code. Pricing reflects that uncertainty unless the application itself gives the underwriter reasons to relax.

Standard underwriting requests at this stage include financial statements or management accounts (even unaudited ones, as long as the books are clean), the investor pitch deck (nearly every carrier wants to review it as part of standard underwriting), a description of internal controls and how financial duties are split up, disclosure of any pending disputes or regulatory inquiries, and documentation of board composition and governance practices.

Good preparation before applying looks fairly mundane, which is sort of the point. Reconcile the cap table so every equity grant is properly documented. Put a basic conflict-of-interest policy in writing and start keeping minutes of board decisions, even informal ones. Separate financial duties even if the whole finance function is one person wearing two hats. And disclose any potential dispute proactively rather than letting an underwriter discover it mid-process, since a surprise found during underwriting slows down binding and can shift the terms in a less favorable direction.

Most carriers offer a bundled D&O and EPLI product at the seed stage, covering both board-level exposure and the employment claims that are statistically likely to hit first. Worth specifically asking for that bundled quote rather than defaulting to standalone D&O and discovering the employment gap later, usually at the worst possible moment.

On timing: start the application process before a term sheet is signed, not after. The standard post-close deadline is 60 to 90 days, but underwriting, negotiation, and binding all take real time, and a covenant breach on day one of a brand-new investor relationship is exactly the kind of avoidable mess that undermines the trust a founder is trying to build with a new board member. Treating D&O as a fundraising prerequisite, something to line up before the ink dries rather than a diligence item to sort out afterward, is the difference between closing a round on schedule and explaining to a lead investor why the binder isn't ready yet.